Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD March 4, 2019 - NASDAQ Companies 0 » View More News for March 04, 2019
